Related Experiment Video
Updated: Aug 17, 2026

Genetic Analysis of Hereditary Transthyretin Ala97Ser Related Amyloidosis
Published on: June 9, 2018
Genetic association between polymorphisms in the ADAMTS14 gene and multiple sclerosis
Robert Goertsches1, Manuel Comabella, Arcadi Navarro
1Unitat de Neuroimmunologia Clínica, Hospital Universitari Vall d'Hebron (HUVH), Escuela de Enfermeria 2(a) planta, Psg Vall d'Hebron 119-129, 08035 Barcelona, Spain.
Abstract:
ADAMTS14 is a novel member of the ADAMTS (a disintegrin-like and metalloproteinase domain with thrombospondin type 1 modules) metalloproteinase family which processes extracellular matrix proteins. In the present study we performed a comprehensive investigation of the ADAMTS14 as a candidate gene for susceptibility to multiple sclerosis (MS). Eight single nucleotide polymorphisms (SNPs) were analyzed in a case-control study of 287 patients with MS [192 with relapsing-remitting MS (RRMS) and 95 with primary-progressive MS (PPMS)], and 285 age- and sex-matched controls. Allele and genotype frequencies were compared between controls and the MS subgroups, and gene-based haplotypes were reconstructed by computational procedures. Pairwise linkage disequilibrium values (D') suggested that three locus pairs (SNPs 3 through 5) had alleles in strong disequilibrium and constituted a haplotype block spanning 14 kb. Overall comparisons of allele and genotype frequencies showed association for SNPs 3 and 6 with MS. Stratification of MS patients according to major clinical forms revealed an increased frequency of both allele C (p = 0.006) and CC homozygosity (p = 0.008) at SNP6 in RRMS patients compared with controls. PPMS was associated with allele A at SNP2 compared with RRMS (p = 0.003) and controls (p = 0.009), and with CG heterozygosity at SNP3 compared with controls (p = 0.005). Haplotype frequency comparisons showed significant association between PPMS and the AGGGC haplotype compared with controls (p = 0.0004), and negative association between RRMS and the GGAGT haplotype compared with controls (p = 0.0026). No association was detected between different genotypes and disease severity measured by the Multiple Sclerosis Severity Score (MSSS). These findings suggest a potentially important role for the ADAMTS14 gene in predisposition to MS.
Insights
The ADAMTS14 gene may play a role in multiple sclerosis (MS) susceptibility. Specific genetic variations in ADAMTS14 were associated with relapsing-remitting MS and primary-progressive MS in a case-control study.
Area of Science:
- Genetics
- Neuroimmunology
- Molecular Biology
Background:
- ADAMTS14 is a metalloproteinase involved in extracellular matrix processing.
- Multiple sclerosis (MS) is a complex neuroinflammatory disease with genetic components.
- Investigating novel candidate genes is crucial for understanding MS predisposition.
Purpose of the Study:
- To comprehensively investigate the ADAMTS14 gene as a candidate for multiple sclerosis (MS) susceptibility.
- To analyze the association between ADAMTS14 single nucleotide polymorphisms (SNPs) and MS risk.
- To explore potential links between ADAMTS14 variants and different clinical forms of MS.
Main Methods:
- A case-control study design was employed.
- Eight single nucleotide polymorphisms (SNPs) in the ADAMTS14 gene were analyzed.
- Allele, genotype, and haplotype frequencies were compared between 287 MS patients and 285 controls.
Main Results:
- Overall, SNPs 3 and 6 in ADAMTS14 showed association with MS.
- Specific variants at SNP6 were linked to an increased risk of relapsing-remitting MS (RRMS).
- Primary-progressive MS (PPMS) showed associations with variants at SNP2 and SNP3, and a specific haplotype (AGGGC).
Conclusions:
- The ADAMTS14 gene is a potential susceptibility factor for multiple sclerosis.
- Genetic variations in ADAMTS14 may influence the risk and potentially the clinical course of MS.
- Further research is warranted to elucidate the functional role of ADAMTS14 in MS pathogenesis.
Related Concept Videos
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
Genome-wide Association Studies-GWAS
GWAS does not require the identification of the target gene involved in...
Multiple Sclerosis l: Introduction
Pharmacogenomics: Identification of New Drug Targets